Metraipolis › archive › dc_995e559c9730

Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases — Europe PMC PMID:41681994

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41681994
DOI
10.3390/cancers18030521
License (as archived)
solo-consultazione
Archived
2026-11-06T02:20:30.086Z
SHA-256 of the archived text
7b087a270e50ee770017f4470621426e5acada955c740aa6695697f2f0410fd4
Stable URL of this page
https://metraipolis.com/documento/dc_995e559c9730

How to cite

Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases — Europe PMC PMID:41681994 — Europe PMC (en), https://europepmc.org/article/MED/41681994 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_995e559c9730 (Metraipolis archive dc_995e559c9730, sha256 7b087a270e50ee770017f4470621426e5acada955c740aa6695697f2f0410fd4)
BibTeX
@misc{dc995e559c9730,
  title = {Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases — Europe PMC PMID:41681994},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41681994},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_995e559c9730; sha256 7b087a270e50ee770017f4470621426e5acada955c740aa6695697f2f0410fd4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41681994. Agents can read the archived copy with the MCP tool read_document.